Smith & Nephew PLC (SNN) KPIs and segments
Close on Nov 16, 2026Market cap –P/E 43.3Yield –
KPIs & segments
Operating metrics and segments that drive Smith & Nephew's business
Smith & Nephew's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orthopaedics($M)4 | 2,437 | 2,305 | 2,214 | 2,113 | 2,156 | 1,917 | 2,222 | 2,168 | 2,107 | |||
Knee Implants($M) | 1,011 | 977 | 940 | 899 | 876 | 822 | 1,042 | 1,017 | 984 | |||
Trauma($M) | 649 | 608 | 564 | 543 | 576 | 460 | 488 | 476 | 479 | |||
Hip Implants($M) | 641 | 619 | 599 | 584 | 612 | 567 | 613 | 613 | 599 | |||
Other Reconstruction($M) | 136 | 101 | 111 | 87 | 92 | 68 | 79 | 62 | 45 | |||
Sports Medicine & ENT($M)3 | 1,934 | 1,824 | 1,729 | 1,590 | 1,560 | 1,333 | 1,536 | 1,461 | 1,402 | |||
Sports Medicine Joint Repair($M) | 1,067 | 982 | 945 | 870 | 839 | 710 | 794 | 717 | 650 | |||
Arthroscopic Enabling Technologies($M) | 647 | 632 | 588 | 567 | 590 | 517 | 591 | 600 | 615 | |||
ENT (Ear, Nose and Throat)($M) | 220 | 210 | 196 | 153 | 131 | 106 | 151 | 144 | 137 | |||
Advanced Wound Management($M)3 | 1,793 | 1,681 | 1,606 | 1,512 | 1,496 | 1,310 | 1,380 | 1,275 | 1,256 | |||
Advanced Wound Care($M) | 766 | 735 | 725 | 712 | 731 | 647 | 701 | 727 | 720 | |||
Advanced Wound Bioactives($M) | 621 | 581 | 553 | 520 | 496 | 431 | 436 | 333 | 342 | |||
Advanced Wound Devices($M) | 406 | 365 | 328 | 280 | 269 | 232 | 243 | 215 | 194 | |||
Orthopaedics, Sports Medicine and ENT and Advanced Wound Management($M) | 5,810 | 5,549 | 5,215 | 5,212 | 4,560 | 5,138 | 4,904 | 4,765 | ||||
Orthopaedics, Sports Medicine & ENT($M) | 4,370 | 4,129 | 3,943 | 3,703 | 3,716 | 3,250 | 3,758 | 3,629 | 3,509 | |||
Advanced Wound Management($M) | 1,794 | 1,681 | 1,606 | 1,512 | 1,496 | 1,310 | 1,380 | 1,275 | 1,256 | 1,233 | ||
Earlier reporting (last reported 2018)10 | ||||||||||||
Sports Medicine & ENT($M) | 461 | 437 | 394 | 472 | 459 | 306 | 489 | |||||
Advanced Wound Management($M) | 447 | 399 | 372 | 436 | 474 | 316 | 370 | |||||
Orthopaedics($M) | 363 | 265 | 251 | 383 | 367 | 389 | 666 | |||||
Earlier reporting (last reported 2022)4 | ||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-03-16.
See a number that looks wrong?